SB10-ASA1,32 8Section 32. 961.01 (20hm) of the statutes is created to read:
SB10-ASA1,22,129 961.01 (20hm) “Qualifying patient" means a person who has been diagnosed
10in the course of a bona fide practitioner-patient relationship as having or undergoing
11a debilitating medical condition or treatment but does not include a person under the
12age of 18 years unless all of the following apply:
SB10-ASA1,22,1513 (a) The person's practitioner has explained the potential risks and benefits of
14the medical use of tetrahydrocannabinols to the person and to a parent, guardian,
15or person having legal custody of the person.
SB10-ASA1,22,1716 (b) The parent, guardian, or person having legal custody provides the
17practitioner a written statement consenting to do all of the following:
SB10-ASA1,22,1818 1. Allow the person's medical use of tetrahydrocannabinols.
SB10-ASA1,22,1919 2. Serve as a primary caregiver for the person.
SB10-ASA1,22,2020 3. Manage the person's medical use of tetrahydrocannabinols.
SB10-ASA1,33 21Section 33. 961.01 (20ht) of the statutes is created to read:
SB10-ASA1,22,2322 961.01 (20ht) “Registry identification card" has the meaning given in s. 146.44
23(1) (g).
SB10-ASA1,34 24Section 34. 961.01 (20t) of the statutes is created to read:
SB10-ASA1,23,2
1961.01 (20t) “Treatment team" means a qualifying patient and his or her
2primary caregivers.
SB10-ASA1,35 3Section 35 . 961.01 (21f) of the statutes is created to read:
SB10-ASA1,23,64 961.01 (21f) “Usable marijuana" means marijuana leaves or flowers but does
5not include seeds, stalks, or roots or any ingredients combined with the leaves or
6flowers.
SB10-ASA1,36 7Section 36. 961.01 (21t) of the statutes is created to read:
SB10-ASA1,23,98 961.01 (21t) “Written certification" means a statement made by a person's
9practitioner if all of the following apply:
SB10-ASA1,23,1310 (a) The statement indicates that, in the practitioner's professional opinion, the
11person has or is undergoing a debilitating medical condition or treatment and the
12potential benefits of the person's use of tetrahydrocannabinols under sub. (14g) (a)
13would likely outweigh the health risks for the person.
SB10-ASA1,23,1514 (b) The statement indicates that the opinion described in par. (a) was made in
15the course of a bona fide practitioner-patient relationship.
SB10-ASA1,23,1716 (c) The statement is signed by the practitioner or is contained in the person's
17medical records.
SB10-ASA1,37 18Section 37. 961.436 of the statutes is created to read:
SB10-ASA1,23,23 19961.436 Medical use defense in cases involving
20tetrahydrocannabinols.
(1) A member of a qualifying patient's treatment team
21has a defense to prosecution under s. 961.41 (1) (h) or (1m) (h) for manufacturing, or
22possessing with intent to manufacture, tetrahydrocannabinols if all of the following
23apply:
SB10-ASA1,23,2524 (a) The manufacture or possession is a medical use of tetrahydrocannabinols
25by the treatment team.
SB10-ASA1,24,2
1(b) The amount of tetrahydrocannabinols does not exceed the maximum
2authorized amount.
SB10-ASA1,24,53 (c) Any live marijuana plants are in a lockable, enclosed facility unless a
4member of a qualifying patient's treatment team is accessing the plants or has the
5plants in his or her possession.
SB10-ASA1,24,76 (d) If the member is a primary caregiver, he or she is not a primary caregiver
7to more than 5 qualifying patients.
SB10-ASA1,24,11 8(2) A member of a qualifying patient's treatment team has a defense to
9prosecution under s. 961.41 (1) (h) or (1m) (h) for distributing or delivering, or
10possessing with intent to distribute or deliver, tetrahydrocannabinols to another
11member of the treatment team if all of the following apply:
SB10-ASA1,24,1312 (a) The distribution, delivery, or possession is a medical use of
13tetrahydrocannabinols by the treatment team.
SB10-ASA1,24,1514 (b) The amount of tetrahydrocannabinols does not exceed the maximum
15authorized amount.
SB10-ASA1,24,1816 (c) Any live marijuana plants are in a lockable, enclosed facility unless a
17member of a qualifying patient's treatment team is accessing the plants or has the
18plants in his or her possession.
SB10-ASA1,24,2019 (d) If the member is a primary caregiver, he or she is not a primary caregiver
20to more than 5 qualifying patients.